Follow us

Follow us

All news

Total 56 Results for:
Clear all filters
  1. Pharmaceuticals and Healthcare

Showing 36 out of 56 results

24 February 2021

Australian IPOs defy early expectations to achieve record end to 2020

The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
7 December 2020

Hiswara Bunjamin & Tandjung advises PT Omni Healthcare on sale of controlling stake in PT Sarana Meditama Metropolitan Tbk

Leading Indonesian law firm Hiswara Bunjamin & Tandjung (HBT) has advised Indonesian hospital group PT Omni Healthcare on the sale of its controlling …
27 November 2020

Herbert Smith Freehills advises on Gland Pharma’s US$872 million India IPO / 史密夫斐尔律师事务所为Gland Pharma 8.72亿美元印度IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised the book running lead managers on the global offering and listing of Gland Pharma Limited on …
20 November 2020

Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …
29 October 2020

Herbert Smith Freehills advises Rosemary Health on Series Seed capital raise

Herbert Smith Freehills’ venture capital team has advised Rosemary Health on its Series Seed capital raise.Rosemary Health is telehealth platform that …
27 October 2020

Herbert Smith Freehills advises sponsors on Simcere Pharmaceutical’s HK$3.57 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为先声药业35.7亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and China International Capital Corporation Hong Kong Securities …
8 July 2020

Herbert Smith Freehills’ finance team advises Crescent Capital Partners on acquisition of PRP Group

Herbert Smith Freehills has advised Crescent Capital Partners on the debt financing aspects of its acquisition of PRP Group. Crescent has been the most …
17 June 2020

Herbert Smith Freehills advises Healius on the sale of its medical and dental centres business

Herbert Smith Freehills’ M&A team has advised Healius Limited on the sale of its medical and dental centres business, with an enterprise value of …
9 June 2020

Herbert Smith Freehills advises Achilles Vaccines in record seed financing for biotech sector

Herbert Smith Freehills has advised Achilles Vaccines, a biotech company focusing on the research and development of vaccines against malaria and other …
27 May 2020

Calls for increased domestic pharmaceutical production not warranted, say Herbert Smith Freehills experts

Increased commentary about Australia’s perceived vulnerability to pharmaceutical shortages have led to recent calls for an overhaul of the country’s …
25 May 2020

Herbert Smith Freehills advises Ramsay Health Care Limited on its capital raising

Herbert Smith Freehills has advised Ramsay Health Care Limited (Ramsay Health Care) on its capital raising, comprising a fully underwritten A$1,200 …
15 May 2020

Herbert Smith Freehills advises sponsors on Peijia Medical’s HK$2.34 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为沛嘉医疗23.4亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors of medical device …